Mount Auburn Hospital in Cambridge, Massachusetts, is a teaching hospital of Harvard Medical School. It was founded by Civil War nurse and administrator Emily Elizabeth Parsons as the first hospital in Cambridge in 1866. It was reopened in 1886 and until 1947 was known as Cambridge Hospital.

During the past decade, Mount Auburn Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Auburn Hospital" #1 sponsor was "Boston Urogynecology Associates" with 4 trials, followed by "ASTORA Women's Health" with 1 trials sponsored, "Agendia" with 1 trials sponsored, "Beth Israel Deaconess Medical Center" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Auburn Hospital" #1 collaborator was "Mount Auburn Hospital" with 2 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "Harvard University" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Open Philanthropy" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Mount Auburn Hospital" are "Sepsis" (2 trials), "Asymptomatic Microscopic Hematuria" (1 trials), "COVID-19" (1 trials), "Colorectal Polyp" (1 trials) and "Fecal Incontinence" (1 trials). Many other conditions were trialed in "Mount Auburn Hospital" in a lesser frequency.

Most popular intervention types in "Mount Auburn Hospital" are "Device" (5 trials), "Drug" (5 trials), "Other" (4 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin" (1 trials), "BKM120" (1 trials), "Computer Aided Detection device" (1 trials), "Cyclophosphamide" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Auburn Hospital" are 9 trials for "Female" genders and 7 trials for "All" genders.

Currently, there are NaN active trials in "Mount Auburn Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Mount Auburn Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mount Auburn Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".